Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bio Green Med Solution's enterprise value is $1.52 Mil.
Bio Green Med Solution's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.63 Mil. Therefore, Bio Green Med Solution's EV-to-EBITDA for today is -0.42.
The historical rank and industry rank for Bio Green Med Solution's EV-to-EBITDA or its related term are showing as below:
BGMS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -2.2 Med: 0.01 Max: 0.24
Current: -0.42
During the past 13 years, the highest EV-to-EBITDA of Bio Green Med Solution was 0.24. The lowest was -2.20. And the median was 0.01.
BGMS's EV-to-EBITDA is ranked worse than 100% of 415
companies
in the Biotechnology industry
Industry Median: 11.92
vs BGMS: -0.42
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Bio Green Med Solution (NAS:BGMS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bio Green Med Solution's PE Ratio (TTM) for today is calculated as:
Bio Green Med Solution's share price for today is $0.88.
Bio Green Med Solution's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.260.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Bio Green Med Solution's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Green Med Solution EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio Green Med Solution's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bio Green Med Solution's EV-to-EBITDA falls into.
Bio Green Med Solution's current Enterprise Value is $1.52 Mil.
Bio Green Med Solution's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.63 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Green Med Solution (BGMS) has a EV-to-EBITDA of -0.42 as of Aug. 04, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bio Green Med Solution. According to the industry distribution chart, Bio Green Med Solution ranks #999999 out of 415 companies in the Biotechnology industry.
Is Bio Green Med Solution's EV-to-EBITDA too high?
Bio Green Med Solution's current EV-to-EBITDA is -0.42. Based on the distribution chart, Bio Green Med Solution ranks #999999 out of 415 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bio Green Med Solution has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio Green Med Solution's EV-to-EBITDA compare to SILO and ALZN?
According to the Biotechnology industry distribution chart, Bio Green Med Solution ranks #999999 out of 415 companies for EV-to-EBITDA. This places Bio Green Med Solution in the lower half of its industry. The industry median EV-to-EBITDA is 11.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 11.92, based on 415 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bio Green Med Solution. For the Biotechnology industry, the median EV-to-EBITDA is 11.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Green Med Solution's current EV-to-EBITDA is -0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Green Med Solution stock overvalued right now?
Based on GuruFocus' analysis, Bio Green Med Solution (BGMS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.56, compared to a current price of $0.88 — trading 65.6% below its estimated fair value. The current EV-to-EBITDA is -0.42. Bio Green Med Solution's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Bio Green Med Solution (BGMS), the current EV-to-EBITDA is -0.42 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio Green Med Solution (BGMS) Overvalued in 2026?
Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued.
The current stock price of $0.88 is trading 65.6% below its estimated GF Value™ of $2.56.
GuruFocus considers Bio Green Med Solution to be Possible Value Trap.
Key valuation signals for BGMS:
EV-to-EBITDA: -0.42
GF Value™: $2.56 vs. price of $0.88 (65.6% below fair value)
No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.
47GF Score
Get the complete analysis for BGMS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGMS has been successfully added to your 
